These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32487084)

  • 1. When is an abscess more than an abscess? Syringe services programs and the harm reduction safety-net: a case report.
    Castillo M; Ginoza MEC; Bartholomew TS; Forrest DW; Greven C; Serota DP; Tookes HE
    Harm Reduct J; 2020 Jun; 17(1):34. PubMed ID: 32487084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast track SSTI management program based on a rapid molecular test (GeneXpert® MRSA/SA SSTI) and antimicrobial stewardship.
    Bouza E; Onori R; Semiglia-Chong MA; Álvarez-Uría A; Alcalá L; Burillo A
    J Microbiol Immunol Infect; 2020 Apr; 53(2):328-335. PubMed ID: 30224283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wounds and Skin and Soft Tissue Infections in People Who Inject Drugs and the Utility of Syringe Service Programs in Their Management.
    Sanchez DP; Tookes H; Pastar I; Lev-Tov H
    Adv Wound Care (New Rochelle); 2021 Oct; 10(10):571-582. PubMed ID: 33913781
    [No Abstract]   [Full Text] [Related]  

  • 4. Police officer attitudes towards syringe services programming.
    Sightes E; Ray B; Paquet SR; Bailey K; Huynh P; Weintraut M
    Drug Alcohol Depend; 2019 Dec; 205():107617. PubMed ID: 31707271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study.
    Ude M; Behrends CN; Kelly S; Schackman BR; Clear A; Goldberg R; Gelberg K; Kapadia SN
    Harm Reduct J; 2023 Feb; 20(1):12. PubMed ID: 36732773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A community-based study of abscess self-treatment and barriers to medical care among people who inject drugs in the United States.
    Ozga JE; Syvertsen JL; Zweifler JA; Pollini RA
    Health Soc Care Community; 2022 Sep; 30(5):1798-1808. PubMed ID: 34469034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Service utilization and cost of implementing a comprehensive HIV prevention and care program among people who inject drugs in Delhi, India.
    Sebastian MP; Dasgupta A; Saraswati LR; Singh A; Sharma V; Madan I; Tun W; Pulerwitz J; Thior I; Sarna A
    Harm Reduct J; 2017 Jun; 14(1):38. PubMed ID: 28615077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL.
    Bartholomew TS; Onugha J; Bullock C; Scaramutti C; Patel H; Forrest DW; Feaster DJ; Tookes HE
    Harm Reduct J; 2020 Jun; 17(1):40. PubMed ID: 32522201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin and soft tissue infections.
    Mistry RD
    Pediatr Clin North Am; 2013 Oct; 60(5):1063-82. PubMed ID: 24093896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin Use in Patients Discharged From the Emergency Department: A Retrospective Observational Cohort Study.
    Mueller K; McCammon C; Skrupky L; Fuller BM
    J Emerg Med; 2015 Jul; 49(1):50-7. PubMed ID: 25802166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital admissions among people who inject opioids following syringe services program implementation.
    Bornstein KJ; Coye AE; St Onge JE; Li H; Muller A; Bartholomew TS; Tookes HE
    Harm Reduct J; 2020 May; 17(1):30. PubMed ID: 32398059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The experiences of people who inject drugs of skin and soft tissue infections and harm reduction: A qualitative study.
    Dunleavy K; Hope V; Roy K; Taylor A
    Int J Drug Policy; 2019 Mar; 65():65-72. PubMed ID: 30665085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI Team.
    Serota DP; Tookes HE; Hervera B; Gayle BM; Roeck CR; Suarez E; Forrest DW; Kolber MA; Bartholomew TS; Rodriguez AE; Doblecki-Lewis S
    Ann Med; 2021 Dec; 53(1):1960-1968. PubMed ID: 34726095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shifting the paradigm: physician-authorized, student-led efforts to provide harm reduction services amidst legislative opposition.
    McMullen TP; Naeim M; Newark C; Oliphant H; Suchard J; Banimahd F
    Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):27. PubMed ID: 33761954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding harm reduction services through a wound and abscess clinic.
    Grau LE; Arevalo S; Catchpool C; Heimer R
    Am J Public Health; 2002 Dec; 92(12):1915-7. PubMed ID: 12453808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013.
    Des Jarlais DC; Nugent A; Solberg A; Feelemyer J; Mermin J; Holtzman D
    MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(48):1337-41. PubMed ID: 26655918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug preparation, injection-related infections, and harm reduction practices among a national sample of individuals entering treatment for opioid use disorder.
    Marks LR; Durkin MJ; Ayres K; Ellis M
    Harm Reduct J; 2024 Jan; 21(1):16. PubMed ID: 38243269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distributive Syringe Sharing and Use of Syringe Services Programs (SSPs) Among Persons Who Inject Drugs.
    Adams M; An Q; Broz D; Burnett J; Wejnert C; Paz-Bailey G;
    AIDS Behav; 2019 Dec; 23(12):3306-3314. PubMed ID: 31512066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences with skin and soft tissue infections among people who inject drugs in Philadelphia: A qualitative study.
    Harris RE; Richardson J; Frasso R; Anderson ED
    Drug Alcohol Depend; 2018 Jun; 187():8-12. PubMed ID: 29626746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Young people who inject drugs in Mozambique: should we emphasize them in the National Harm Reduction Plan?
    Semá Baltazar C; Boothe M; Kellogg T
    Harm Reduct J; 2020 Mar; 17(1):20. PubMed ID: 32216809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.